San Diego, CA, United States of America

Mitchell Carl

This inventor holds 1 USPTO granted patent. Top assignee: USA as Represented by Secretary of the Navy. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitchell Carl. Retrieved from https://idiyas.com/inventor/mitchell-carl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mitchell Carl

Introduction

Mitchell Carl is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His work focuses on the genetic and protein components that can be utilized for vaccination against specific diseases.

Latest Patents

Mitchell Carl holds a patent for a gene and protein applicable to the preparation of vaccines. This patent includes all or part of the DNA sequence of the gene encoding the S-layer protein of R. prowazekii, as illustrated in Sequence ID No. 1. The invention also encompasses a truncated identical piece of this gene in R. typhi, along with the 5' and 3' noncoding regions. These components can be used for vaccination against typhus and spotted fever rickettsial infections or for diagnosing the diseases caused by these bacteria. Additionally, the invention includes the deduced amino acid sequence of the S-layer protein of R. prowazekii derived from the DNA sequence of the encoding gene, as well as peptide or protein products based on all or parts of this gene. He has 1 patent to his name.

Career Highlights

Mitchell Carl works for the United States as represented by the Secretary of the Navy. His role involves significant research and development efforts aimed at improving public health through innovative vaccine solutions. His expertise in biotechnology has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Mitchell has collaborated with notable colleagues, including Michael E. Dobson and Wei-Mei Ching. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.

Conclusion

Mitchell Carl's contributions to vaccine development highlight the importance of innovation in biotechnology. His work not only advances scientific knowledge but also has the potential to improve public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…